|

Etoposide + carboplatin; Etoposide + cisplatin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Sun Yat-sen University1

Indications

  • Progression1
  • Radiation Exposure1
  • SCLC, Limited Stage1
  • Radiotherapy Side Effect1
  • Lung Cancer1

Other1 trial

Omitting CTV for Primary Tumor in LS-SCLC
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.